UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057844
Receipt number R000065751
Scientific Title A Study on the Predictive Ability of Dynamic Arterial Elastance for Cardiac Output Increase Following Vasopressor Administration
Date of disclosure of the study information 2025/05/13
Last modified on 2025/05/13 00:29:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Predictive Ability of Dynamic Arterial Elastance for Cardiac Output Increase Following Vasopressor Administration

Acronym

A Study on the Predictive Ability of Dynamic Arterial Elastance for Cardiac Output Increase Following Vasopressor Administration

Scientific Title

A Study on the Predictive Ability of Dynamic Arterial Elastance for Cardiac Output Increase Following Vasopressor Administration

Scientific Title:Acronym

A Study on the Predictive Ability of Dynamic Arterial Elastance for Cardiac Output Increase Following Vasopressor Administration

Region

Japan


Condition

Condition

Patients scheduled for surgery under general anesthesia with planned arterial catheter insertion

Classification by specialty

Anesthesiology Operative medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

During general anesthesia, vasopressors exhibit both preload- and afterload-increasing effects. Following vasopressor administration, stroke volume (and thus cardiac output) may either increase or decrease. The study aims to investigate whether Eadyn can predict the direction of change in cardiac output induced by vasopressor use.

Basic objectives2

Others

Basic objectives -Others

This study investigates whether Eadyn can predict an increase in cardiac output following continuous vasopressor administration in response to hypotension during general anesthesia.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in stroke volume before and 10 minutes after initiation of continuous vasopressor infusion (norepinephrine at 0.05 mcg/kg/min, up to a maximum of 0.1 mcg/kg/min)

Key secondary outcomes

Change in cardiac output before and 10 minutes after initiation of continuous vasopressor infusion (norepinephrine at 0.05 mcg/kg/min assumed)
Change in stroke volume and cardiac output before and 2 minutes after a single bolus of phenylephrine (0.1 mg); if multiple doses are administered, only the first dose is evaluated
Assessment of the effectiveness of continuous vasopressor infusion: whether mean arterial pressure (MAP) reaches >65 mmHg, and/or whether MAP increases by >10%


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing general anesthesia for surgery with planned arterial catheter insertion and intraoperative cardiac output monitoring

Key exclusion criteria

Patients with an ejection fraction <40%
Patients with atrial fibrillation
Patients with severe chronic obstructive pulmonary disease (COPD)
Patients with right heart failure
Patients with severe obesity (BMI>35)
Patients with severe underweight or cachexia (BMI<15)
Patients with preoperatively diagnosed hyperthyroidism

Target sample size

42


Research contact person

Name of lead principal investigator

1st name YUSUKE
Middle name
Last name IIZUKA

Organization

Saitama Medical center, Jichi medical university

Division name

Department of anesthesiology and critical care medicine

Zip code

3308503

Address

1-847, amanuma town, Omiya-ku, Saitama City, Saitama, Japan

TEL

+81486472111

Email

zukarinn@gmail.com


Public contact

Name of contact person

1st name YUSUKE
Middle name
Last name IIZUKA

Organization

Jichi medical university, saitama medical center

Division name

Department of anesthesiology and critical care medicine

Zip code

330-8503

Address

1-847, amanuma town, Omiya-ku, Saitama City, Saitama, Japan

TEL

+81486472111

Homepage URL


Email

zukarinn@gmail.com


Sponsor or person

Institute

jichi medical university

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Anesthesiology and Critical care medicine, Jichi medical university, Saitama medical center

Address

1-847, amanuma town, Omiya-ku, Saitama City, Saitama, Japan

Tel

+81486472111

Email

s-suishin@jichi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 03 Month 25 Day

Date of IRB

2025 Year 03 Month 25 Day

Anticipated trial start date

2025 Year 04 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2025 Year 05 Month 13 Day

Last modified on

2025 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065751